Saturday, March 21, 2020

7:30 am REGISTRATION / CONTINENTAL BREAKFAST
Vaquero Ballroom Foyer
7:50 am Welcome and Opening Remarks

David G. Rizik, MD

Arizona Ballroom, Level 1

UNRESOLVED ISSUES IN TAVR I
  Moderators: David A. Cox, MD and Mattias Götberg, MD, PhD

Panelists: Robert J. Applegate, MD; Dawn Hui, MD; Srinivas Iyengar, MD; Merick Kirshner, MD; Michael J. Reardon, MD; Steven J. Yakubov, MD  

                                    

8:00 am Evolution of Aortic Valve Therapies: SAVR to TAVR; the Surgeon’s Perspective

Dawn Hui, MD

 

8:10 am Why I Still Like Edwards S3 

Robert J. Applegate, MD

 

8:20 am Why I Like the New Evolut Pro+ 

Steven J. Yakubov, MD  

 

8:30 am Why I like Portico’s FlexNav System 

James B. Hermiller, MD

 

8:40 am Why I Like the Lotus Edge System

David G. Rizik, MD

 

8:50 am Valve-in-Valve TAVR I: Predicting When the Coronaries Are at Risk

Mark Reisman, MD 

 

9:00 am Valve-in-Valve TAVR II: Basilica the ABCs and Other Ways to Bail Out the Coronaries

Ramon Quesada, MD

 

9:10 am Valve-in-Valve TAVR III: When to Crack and When to Wave the White Flag

Saif Anwaruddin, MD

 

LIVE CASE 11
9:20 am

 

LIVE CASE 11 | TAVR

Transmitted from Banner University Medical Center Phoenix

Phoenix, AZ

Lab: Ashish Pershad, MD

 

9:50 am BREAK / VISIT EXHIBITS
UNRESOLVED ISSUES IN TAVR II
  Moderators: James B. Hermiller, MD and David G. Rizik, MD

Panelists: Neil M. Gheewala, MD; Kendra J. Grubb, MD; Nishant Gupta, MD; Katherine B. Harrington, MD; Merick A. Kirshner, MD; Brijeshwar S. Maini, MD; Michael J. Reardon, MD; Michael J. Rinaldi, MD  

 

DEBATE: CEREBRAL EMBOLIC PROTECTION
10:00 am Con Position – Cerebral Protection: Insufficient Clinical Data & Too Costly

Mark Reisman, MD

 

10:10 am Pro Position – CEP for Everyone: The Data are Compelling, the Cost Manageable

Michael J. Rinaldi, MD  

 

10:20 am

 

Should ALL Trileaflet AS be Treated with TAVR?

James B. Hermiller, MD

 

10:30 am

 

Technical Aspects of Cerebral Embolic Protection

Carlos Sanchez, MD

 

10:40 am Incidence of AS will Double by 2040: What that Means for TAVR Programs

Binita Shah, MD

 

10:50 am Optimizing TAVR Program: From First Contact Through Discharge

Molly Szerlip, MD

 

11:00 am TAVR Access: A to Z

Kendra J. Grubb, MD

 

11:10 am With all the Transcatheter Therapy, Can We Sustain Great Surgeons?

Michael J. Reardon, MD

 

11:20 am Strategies for the Non-Surgical AI Patient  

John M. Lasala, MD, PhD  

LIVE CASE 12
11:30 am

 

LIVE CASE 12 | TAVR

Transmitted from HonorHealth Scottsdale Shea Medical Center

Scottsdale, AZ

Lab: David G. Rizik, MD; Matthias Götberg, MD, PhD; Robert D. Riley, MD

 

12:00 pm TAVR for Bicuspid Disease: Best Practices  

Brijeshwar S. Maini, MD

 

12:10 pm Low Risk Aortic Stenosis: Who Should Not Get TAVR in 2020

Katherine B. Harrington, MD

 

12:20 pm Panel Discussion and Closing Remarks

David G. Rizik, MD